Læknablaðið - 15.10.1990, Síða 23

LÆKNABLAÐIÐ
389
7. Mavroudis C, Cook LN, Fleischaker JW, et al.
Management of patent ductus arteriosus in the
premature infant: Indomethacin versus ligation. Ann
Thorac Surg 1983; 36: 561-6.
8. Powell ML. Patent ductus arteriosus in premature
infants. Med J Aust 1963; 2: 58-60.
9. Gross RE. Hubbard JP. Surgical ligation of patent
ductus arteriosus: Report öf first successful case.
JAMA 1939; 112: 729-31.
10. Gersony WM, Peckham GJ, Curtis Ellison R,
Miettinen OS, Nadas AS. Effects of indomethacin
in premature infants with patent ductus arteriosus:
Results of a national collaborative study. J Pediatr
1983; 102 (6): 895-906.
11. Dasmahapatra HK, Sethia B, Pollock JCS. Surgical
closure of persistent ductus arteriosus (PDA) in
infants before 30 weeks gestation. J Cardiovasc Surg
1986; 27: 675-8.
12. Palder SB, Schwartz MZ, Tyson KRT, Marr
CC. Management of patent ductus arteriosus: A
comparison of operative v. pharmacologic treatment.
J Ped Surg 1987; 22 (12); 1171-4.
13. Evans WN, Cass KA, Feldman BH. Indomethacin
therapy for patent ductus arteriosus. AJDC 1987; 141:
1042.
14. Cowan F. Indomethacin, patent ductus arteriosus and
cerebral blood flow. J Pediatr 1986; 109 (2): 341-3.
15. Pryds O, Greisen G, Johansen KH. Indomethacin and
cerebral blood flow in premature infants treated for
patent ductus arteriosus. Eur J Pediatr 1988; 147:
315-6.
16. Júlíusson B, Þórarinsson H, Ólafsson G. Ductus
arteriosus persistens. Læknablaðið 1976; 62: 53-7.